Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 02, 2015 5:54 PM ET

Healthcare Equipment and Supplies

Company Overview of Second Sight Medical Products, Inc.

Company Overview

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable prosthetic devices to restore functional vision to blind patients in the United States, Canada, Europe, and Saudi Arabia. It offers Argus II System, an implantable neurostimulation device that uses electrical stimulation of the retina to replace the function of the defunct photo-receptors in retinitis pigmentosa patients. Second Sight Medical Products, Inc. sells its Argus II System to university hospitals, teaching hospitals, medical centers, and ambulatory surgical centers. The company was formerly known as Second Sight LLC. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Syl...

12744 San Fernando Road

Building 3

Sylmar, CA 91342

United States

Founded in 1998

121 Employees





Key Executives for Second Sight Medical Products, Inc.

Chief Executive Officer, President and Director
Age: 47
Total Annual Compensation: $377.5K
Chief Financial Officer
Age: 59
Total Annual Compensation: $144.4K
Vice President of European Operations
Age: 43
Total Annual Compensation: $220.6K
Vice President of Clinical and Regulatory Affairs
Age: 45
Total Annual Compensation: $219.5K
Vice President of Manufacturing
Age: 57
Total Annual Compensation: $204.2K
Compensation as of Fiscal Year 2014.

Second Sight Medical Products, Inc. Key Developments

Second Sight Medical Products, Inc. Announces Management Changes

On June 19, 2015, Second Sight Medical Products, Inc. and Will McGuire entered into employment agreement pursuant to which the company appointed Mr. McGuire as Chief Executive Officer and President effective no later than August 18, 2015. Mr. McGuire was also appointed to the Board of Directors effective upon his assumption of duties as CEO and President of the company. Mr. McGuire will be responsible for management and control of the business, affairs and properties of the company. Mr. McGuire joins Second Sight from Volcano Corporation, where he was President of Americas Commercial since 2014 and prior to that, Senior Vice President and General Manager of Coronary Imaging, Systems and Program Management since 2013. Prior to joining Volcano, Mr. McGuire served as Vice President and General Manager of Patient Monitoring at Covidien. He previously served as President and Chief Executive Officer of AtheroMed, Inc. Mr. McGuire succeeds Dr. Robert Greenberg, who will become Chairman of the Board of Directors of Second Sight, replacing Alfred Mann, who will assume the role of Chairman Emeritus.

Second Sight Announces Positive Long-Term Results of the Argus II Retinal Prosthesis System

Second Sight Medical Products, Inc. announced positive three year results post-implant of its Argus® II Retinal Prosthesis System (“Argus II”) from a multi-center clinical trial. Three types of visual function tests were performed using computer-run assessments: square localization (that is object detection), direction of motion (that is motion detection) and discrimination of oriented gratings (that is visual acuity). Two types of real-world orientation and mobility (O&M) tests were also performed: a test where subjects were asked to locate and touch a door, as well as a test where subjects were asked to follow a white line on the floor. In the absence of existing validated quality of life tools for this population, a Functional Low-vision Observer Rated Assessment (FLORA) was also performed by independent visual rehabilitation experts at the request of the FDA to assess the impact of the Argus II system on the subjects’ everyday lives, including extensive interviews and tasks performed around the home. Of the 30 subjects tested, 29 remained implanted with functioning Argus II systems at three years post-implant. Results showed that with the Argus II System, improvements in visual function and O&M were maintained out to three years. Up to 89% of subjects performed statistically better with the Argus II system implanted compared with native residual vision in visual function tasks at year three. During the trial, the FLORA also demonstrated that up to 80% of the subjects received benefit from the system when considering both functional vision and patient-reported quality of life, and no subjects were affected negatively. The results of the trial support the long-term safety profile and benefit of the Argus II for individuals who are blind due to retinitis pigmentosa (RP).

Second Sight Medical Products, Inc. Presents at JMP Securities Life Sciences Conference, Jun-24-2015 01:00 PM

Second Sight Medical Products, Inc. Presents at JMP Securities Life Sciences Conference, Jun-24-2015 01:00 PM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States. Speakers: Robert J. Greenberg, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
MedTrak Technologies, Inc. United States
Nivasonix, LLC United States
American OsteoMedix Corporation United States
Royce Medical Company Inc. United States
MSR, Incorporated United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Second Sight Medical Products, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at